Request Deal Involvement

Gimv, Samsara Biocapital and Lightspeed Venture Partners ed a $74m Series B funding round in ImmunOs Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Vischer

legal advisors

Vischer

or

Principals

PEAK6 INVESTMENTS

bidder

PEAK6 INVESTMENTS

GIMV NV

bidder

GIMV NV

GL CAPITAL GROUP

bidder

GL CAPITAL GROUP

IMMUNOS THERAPEUTICS

target

IMMUNOS THERAPEUTICS

BIOMEDPARTNERS

bidder

BIOMEDPARTNERS

SAMSARA BIOCAPITAL

bidder

SAMSARA BIOCAPITAL

FISCUS FINANCIAL

bidder

FISCUS FINANCIAL

LIGHTSPEED VENTURE PARTNERS

bidder

LIGHTSPEED VENTURE PARTNERS

MISSION BIOCAPITAL

bidder

MISSION BIOCAPITAL

PFIZER VENTURES

bidder

PFIZER VENTURES

SCHRODER ADVEQ

bidder

SCHRODER ADVEQ

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Gimv, Samsara Biocapital and Lightspeed Venture Partners ed a $74m Series B funding round in ImmunOs Therapeutics.